NCT05274880View on ClinicalTrials.gov

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

July 15, 2022

Study Completion Date

July 26, 2022

Conditions
Type II Diabetes Mellitus
Interventions
DRUG

CKD-393

PO, QD

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT05274880 - Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 | Biotech Hunter | Biotech Hunter